Zhou et al. [29] studied the effect of KIAA1211 mutations and TMB on the prognosis of non-small-cell lung cancer patients and performed survival analysis, demonstrating that both TMB level and high expression of KIAA1211 are related to a good prognostic factor for non-small-cell lung cancer, and similarly, KIAA1211 mutant frequency is positively correlated with TMB level. The gene discussed is CRACD; the disease is non-small cell lung carcinoma.